Pfizer COVID Vaccine Shows Alarming Evidence of Pathogenic Priming in Older Adults
Pfizer COVID Vaccine Trial Shows Alarming Evidence of Pathogenic Priming in Older Adults
In the development of vaccines against coronaviruses like SARS-COV-1 and MERS in the early 2000’s, researchers found evidence of a serious problem. Teams of U.S. and foreign scientists vaccinated animals with the four most promising vaccines. At first, the experiment seemed successful as all the animals developed a robust antibody response to coronavirus. However, when the scientists exposed the vaccinated animals to the wild virus, the results were horrifying. Vaccinated animals suffered hyper-immune responses including inflammation throughout their bodies, especially in their lungs.
The first issue is the categorization of “Serious vs. Non-Serious” adverse events in the study and in the report. To a person experiencing neurologic adverse events including Bell’s Palsy, neuroinflammatory and thrombotic events, these events are not “non-serious” and can, over time, develop into life-threatening conditions that require continuous medical intervention and repeated billable office visits for care. The short-term study excludes any means of detecting whether the initial exposure may play a fundamental root cause role in setting up patients for life-long chronic illness. The vaccine adverse events themselves seen in the Pfizer study may be indicative of pathogenic priming, especially since more serious adverse events were seen with the second dose.
READ THE FULL STORY: https://childrenshealthdefense.org/defender/pfizer-covid-vaccine-trial-pathogenic-priming/